ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aprepitant Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22G10300
Home | Market Reports | Health| Pharmacy
Global and United States Aprepitant Market Report Forecast 2022 2028
BUY CHAPTERS

Global Aprepitant Market Research Report 2025

Code: QYRE-Auto-22G10300
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Heron Therapeutics
Sandoz Inc
Glenmark Pharmaceuticals
Actiza Pharmaceutical
Aetos Pharma
Shanghai Yingrui Biomedical Technology Co., Ltd.
Vea Impex (I) Pvt. Ltd.
Aark Pharmaceuticals

Aprepitant Market Size

The global market for Aprepitant was valued at US$ 78.6 million in the year 2024 and is projected to reach a revised size of US$ 102 million by 2031, growing at a CAGR of 3.8% during the forecast period.

Aprepitant Market

Aprepitant Market

Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
Aprepitant is a medication used for preventing nausea and vomiting caused by chemotherapy. The global market for aprepitant is primarily driven by several factors. The increasing incidence of cancer worldwide is a major driver for the aprepitant market. Chemotherapy is one of the primary treatment modalities for cancer, and nausea and vomiting are common side effects of chemotherapy. Aprepitant has been proven effective in preventing these side effects, making it a vital medication in managing the quality of life for cancer patients. The rising awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment is contributing to the market growth. Improved education and understanding about the side effects of chemotherapy and the availability of medications like aprepitant have led to increased demand. The growing adoption of combination therapies in cancer treatment is driving the demand for aprepitant. Aprepitant is often used in combination with other antiemetic medications to provide a comprehensive approach in preventing chemotherapy-induced nausea and vomiting. The development of generic versions of aprepitant is also contributing to its market growth. Generic versions offer cost savings and improved accessibility for patients, leading to increased adoption. The expansion of healthcare infrastructure, especially in emerging markets, is playing a significant role in driving the global market for aprepitant. As more healthcare facilities and cancer treatment centers are established, the demand for aprepitant is expected to rise. Ongoing research and development activities aimed at exploring new indications and formulations for aprepitant are further driving the market. For example, studies are being conducted to evaluate the efficacy of aprepitant in other conditions associated with nausea and vomiting, such as postoperative nausea and vomiting.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aprepitant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant.
The Aprepitant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aprepitant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Aprepitant Market Report

Report Metric Details
Report Name Aprepitant Market
Accounted market size in year US$ 78.6 million
Forecasted market size in 2031 US$ 102 million
CAGR 3.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck & Co., Heron Therapeutics, Sandoz, Glenmark Pharmaceuticals, Shanghai Yingrui Biomedical Technology Co., Ltd., Vea Impex (I) Pvt. Ltd., Aark Pharmaceuticals, Actiza Pharmaceutical, Aetos Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Aprepitant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Aprepitant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Aprepitant Market growing?

Ans: The Aprepitant Market witnessing a CAGR of 3.8% during the forecast period 2025-2031.

What is the Aprepitant Market size in 2031?

Ans: The Aprepitant Market size in 2031 will be US$ 102 million.

Who are the main players in the Aprepitant Market report?

Ans: The main players in the Aprepitant Market are Merck & Co., Heron Therapeutics, Sandoz, Glenmark Pharmaceuticals, Shanghai Yingrui Biomedical Technology Co., Ltd., Vea Impex (I) Pvt. Ltd., Aark Pharmaceuticals, Actiza Pharmaceutical, Aetos Pharma

What are the Application segmentation covered in the Aprepitant Market report?

Ans: The Applications covered in the Aprepitant Market report are Hospital, Drug store

What are the Type segmentation covered in the Aprepitant Market report?

Ans: The Types covered in the Aprepitant Market report are Injection, Oral

Recommended Reports

Cancer Treatment Drugs

Cancer Support & Adjuncts

Oncology Drug APIs

1 Aprepitant Market Overview
1.1 Product Definition
1.2 Aprepitant by Type
1.2.1 Global Aprepitant Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Oral
1.3 Aprepitant by Application
1.3.1 Global Aprepitant Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Aprepitant Market Size Estimates and Forecasts
1.4.1 Global Aprepitant Revenue 2020-2031
1.4.2 Global Aprepitant Sales 2020-2031
1.4.3 Global Aprepitant Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Aprepitant Market Competition by Manufacturers
2.1 Global Aprepitant Sales Market Share by Manufacturers (2020-2025)
2.2 Global Aprepitant Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Aprepitant Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Aprepitant, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aprepitant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aprepitant, Product Type & Application
2.7 Global Key Manufacturers of Aprepitant, Date of Enter into This Industry
2.8 Global Aprepitant Market Competitive Situation and Trends
2.8.1 Global Aprepitant Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aprepitant Players Market Share by Revenue
2.8.3 Global Aprepitant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aprepitant Market Scenario by Region
3.1 Global Aprepitant Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Aprepitant Sales by Region: 2020-2031
3.2.1 Global Aprepitant Sales by Region: 2020-2025
3.2.2 Global Aprepitant Sales by Region: 2026-2031
3.3 Global Aprepitant Revenue by Region: 2020-2031
3.3.1 Global Aprepitant Revenue by Region: 2020-2025
3.3.2 Global Aprepitant Revenue by Region: 2026-2031
3.4 North America Aprepitant Market Facts & Figures by Country
3.4.1 North America Aprepitant Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Aprepitant Sales by Country (2020-2031)
3.4.3 North America Aprepitant Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aprepitant Market Facts & Figures by Country
3.5.1 Europe Aprepitant Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Aprepitant Sales by Country (2020-2031)
3.5.3 Europe Aprepitant Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aprepitant Market Facts & Figures by Region
3.6.1 Asia Pacific Aprepitant Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Aprepitant Sales by Region (2020-2031)
3.6.3 Asia Pacific Aprepitant Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aprepitant Market Facts & Figures by Country
3.7.1 Latin America Aprepitant Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Aprepitant Sales by Country (2020-2031)
3.7.3 Latin America Aprepitant Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aprepitant Market Facts & Figures by Country
3.8.1 Middle East and Africa Aprepitant Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Aprepitant Sales by Country (2020-2031)
3.8.3 Middle East and Africa Aprepitant Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aprepitant Sales by Type (2020-2031)
4.1.1 Global Aprepitant Sales by Type (2020-2025)
4.1.2 Global Aprepitant Sales by Type (2026-2031)
4.1.3 Global Aprepitant Sales Market Share by Type (2020-2031)
4.2 Global Aprepitant Revenue by Type (2020-2031)
4.2.1 Global Aprepitant Revenue by Type (2020-2025)
4.2.2 Global Aprepitant Revenue by Type (2026-2031)
4.2.3 Global Aprepitant Revenue Market Share by Type (2020-2031)
4.3 Global Aprepitant Price by Type (2020-2031)
5 Segment by Application
5.1 Global Aprepitant Sales by Application (2020-2031)
5.1.1 Global Aprepitant Sales by Application (2020-2025)
5.1.2 Global Aprepitant Sales by Application (2026-2031)
5.1.3 Global Aprepitant Sales Market Share by Application (2020-2031)
5.2 Global Aprepitant Revenue by Application (2020-2031)
5.2.1 Global Aprepitant Revenue by Application (2020-2025)
5.2.2 Global Aprepitant Revenue by Application (2026-2031)
5.2.3 Global Aprepitant Revenue Market Share by Application (2020-2031)
5.3 Global Aprepitant Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Company Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck & Co. Aprepitant Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Heron Therapeutics
6.2.1 Heron Therapeutics Company Information
6.2.2 Heron Therapeutics Description and Business Overview
6.2.3 Heron Therapeutics Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Heron Therapeutics Aprepitant Product Portfolio
6.2.5 Heron Therapeutics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Company Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sandoz Aprepitant Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Glenmark Pharmaceuticals
6.4.1 Glenmark Pharmaceuticals Company Information
6.4.2 Glenmark Pharmaceuticals Description and Business Overview
6.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Glenmark Pharmaceuticals Aprepitant Product Portfolio
6.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.5 Shanghai Yingrui Biomedical Technology Co., Ltd.
6.5.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
6.5.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Description and Business Overview
6.5.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio
6.5.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments/Updates
6.6 Vea Impex (I) Pvt. Ltd.
6.6.1 Vea Impex (I) Pvt. Ltd. Company Information
6.6.2 Vea Impex (I) Pvt. Ltd. Description and Business Overview
6.6.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio
6.6.5 Vea Impex (I) Pvt. Ltd. Recent Developments/Updates
6.7 Aark Pharmaceuticals
6.7.1 Aark Pharmaceuticals Company Information
6.7.2 Aark Pharmaceuticals Description and Business Overview
6.7.3 Aark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Aark Pharmaceuticals Aprepitant Product Portfolio
6.7.5 Aark Pharmaceuticals Recent Developments/Updates
6.8 Actiza Pharmaceutical
6.8.1 Actiza Pharmaceutical Company Information
6.8.2 Actiza Pharmaceutical Description and Business Overview
6.8.3 Actiza Pharmaceutical Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Actiza Pharmaceutical Aprepitant Product Portfolio
6.8.5 Actiza Pharmaceutical Recent Developments/Updates
6.9 Aetos Pharma
6.9.1 Aetos Pharma Company Information
6.9.2 Aetos Pharma Description and Business Overview
6.9.3 Aetos Pharma Aprepitant Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aetos Pharma Aprepitant Product Portfolio
6.9.5 Aetos Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aprepitant Industry Chain Analysis
7.2 Aprepitant Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aprepitant Production Mode & Process Analysis
7.4 Aprepitant Sales and Marketing
7.4.1 Aprepitant Sales Channels
7.4.2 Aprepitant Distributors
7.5 Aprepitant Customer Analysis
8 Aprepitant Market Dynamics
8.1 Aprepitant Industry Trends
8.2 Aprepitant Market Drivers
8.3 Aprepitant Market Challenges
8.4 Aprepitant Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Heron Therapeutics
Sandoz Inc
Glenmark Pharmaceuticals
Actiza Pharmaceutical
Aetos Pharma
Shanghai Yingrui Biomedical Technology Co., Ltd.
Vea Impex (I) Pvt. Ltd.
Aark Pharmaceuticals
List of Tables
 Table 1. Global Aprepitant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Aprepitant Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Aprepitant Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Aprepitant Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Aprepitant Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Aprepitant Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Aprepitant Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Aprepitant Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Aprepitant, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Aprepitant, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Aprepitant, Product Type & Application
 Table 12. Global Key Manufacturers of Aprepitant, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Aprepitant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Aprepitant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Aprepitant Sales by Region (2020-2025) & (K Units)
 Table 18. Global Aprepitant Sales Market Share by Region (2020-2025)
 Table 19. Global Aprepitant Sales by Region (2026-2031) & (K Units)
 Table 20. Global Aprepitant Sales Market Share by Region (2026-2031)
 Table 21. Global Aprepitant Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Aprepitant Revenue Market Share by Region (2020-2025)
 Table 23. Global Aprepitant Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Aprepitant Revenue Market Share by Region (2026-2031)
 Table 25. North America Aprepitant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Aprepitant Sales by Country (2020-2025) & (K Units)
 Table 27. North America Aprepitant Sales by Country (2026-2031) & (K Units)
 Table 28. North America Aprepitant Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Aprepitant Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Aprepitant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Aprepitant Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Aprepitant Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Aprepitant Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Aprepitant Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Aprepitant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Aprepitant Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Aprepitant Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Aprepitant Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Aprepitant Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Aprepitant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Aprepitant Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Aprepitant Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Aprepitant Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Aprepitant Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Aprepitant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Aprepitant Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Aprepitant Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Aprepitant Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Aprepitant Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Aprepitant Sales (K Units) by Type (2020-2025)
 Table 51. Global Aprepitant Sales (K Units) by Type (2026-2031)
 Table 52. Global Aprepitant Sales Market Share by Type (2020-2025)
 Table 53. Global Aprepitant Sales Market Share by Type (2026-2031)
 Table 54. Global Aprepitant Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Aprepitant Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Aprepitant Revenue Market Share by Type (2020-2025)
 Table 57. Global Aprepitant Revenue Market Share by Type (2026-2031)
 Table 58. Global Aprepitant Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Aprepitant Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Aprepitant Sales (K Units) by Application (2020-2025)
 Table 61. Global Aprepitant Sales (K Units) by Application (2026-2031)
 Table 62. Global Aprepitant Sales Market Share by Application (2020-2025)
 Table 63. Global Aprepitant Sales Market Share by Application (2026-2031)
 Table 64. Global Aprepitant Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Aprepitant Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Aprepitant Revenue Market Share by Application (2020-2025)
 Table 67. Global Aprepitant Revenue Market Share by Application (2026-2031)
 Table 68. Global Aprepitant Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Aprepitant Price (USD/Unit) by Application (2026-2031)
 Table 70. Merck & Co. Company Information
 Table 71. Merck & Co. Description and Business Overview
 Table 72. Merck & Co. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Merck & Co. Aprepitant Product
 Table 74. Merck & Co. Recent Developments/Updates
 Table 75. Heron Therapeutics Company Information
 Table 76. Heron Therapeutics Description and Business Overview
 Table 77. Heron Therapeutics Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Heron Therapeutics Aprepitant Product
 Table 79. Heron Therapeutics Recent Developments/Updates
 Table 80. Sandoz Company Information
 Table 81. Sandoz Description and Business Overview
 Table 82. Sandoz Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Sandoz Aprepitant Product
 Table 84. Sandoz Recent Developments/Updates
 Table 85. Glenmark Pharmaceuticals Company Information
 Table 86. Glenmark Pharmaceuticals Description and Business Overview
 Table 87. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Glenmark Pharmaceuticals Aprepitant Product
 Table 89. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 90. Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
 Table 91. Shanghai Yingrui Biomedical Technology Co., Ltd. Description and Business Overview
 Table 92. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product
 Table 94. Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments/Updates
 Table 95. Vea Impex (I) Pvt. Ltd. Company Information
 Table 96. Vea Impex (I) Pvt. Ltd. Description and Business Overview
 Table 97. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Vea Impex (I) Pvt. Ltd. Aprepitant Product
 Table 99. Vea Impex (I) Pvt. Ltd. Recent Developments/Updates
 Table 100. Aark Pharmaceuticals Company Information
 Table 101. Aark Pharmaceuticals Description and Business Overview
 Table 102. Aark Pharmaceuticals Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Aark Pharmaceuticals Aprepitant Product
 Table 104. Aark Pharmaceuticals Recent Developments/Updates
 Table 105. Actiza Pharmaceutical Company Information
 Table 106. Actiza Pharmaceutical Description and Business Overview
 Table 107. Actiza Pharmaceutical Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Actiza Pharmaceutical Aprepitant Product
 Table 109. Actiza Pharmaceutical Recent Developments/Updates
 Table 110. Aetos Pharma Company Information
 Table 111. Aetos Pharma Description and Business Overview
 Table 112. Aetos Pharma Aprepitant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Aetos Pharma Aprepitant Product
 Table 114. Aetos Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Aprepitant Distributors List
 Table 118. Aprepitant Customers List
 Table 119. Aprepitant Market Trends
 Table 120. Aprepitant Market Drivers
 Table 121. Aprepitant Market Challenges
 Table 122. Aprepitant Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Aprepitant
 Figure 2. Global Aprepitant Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Aprepitant Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Oral Product Picture
 Figure 6. Global Aprepitant Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Aprepitant Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug store
 Figure 10. Global Aprepitant Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Aprepitant Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Aprepitant Sales (2020-2031) & (K Units)
 Figure 13. Global Aprepitant Average Price (USD/Unit) & (2020-2031)
 Figure 14. Aprepitant Report Years Considered
 Figure 15. Aprepitant Sales Share by Manufacturers in 2024
 Figure 16. Global Aprepitant Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Aprepitant Players: Market Share by Revenue in Aprepitant in 2024
 Figure 18. Aprepitant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Aprepitant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Aprepitant Sales Market Share by Country (2020-2031)
 Figure 21. North America Aprepitant Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Aprepitant Sales Market Share by Country (2020-2031)
 Figure 25. Europe Aprepitant Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Aprepitant Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Aprepitant Revenue Market Share by Region (2020-2031)
 Figure 33. China Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Aprepitant Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Aprepitant Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Aprepitant Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Aprepitant Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Aprepitant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Aprepitant by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Aprepitant by Type (2020-2031)
 Figure 55. Global Aprepitant Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Aprepitant by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Aprepitant by Application (2020-2031)
 Figure 58. Global Aprepitant Price (USD/Unit) by Application (2020-2031)
 Figure 59. Aprepitant Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Aprepitant API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NK 1 Receptor Antagonists Market Research Report 2024
Global Neurokinin Receptor Antagonists Market Research Report 2024
Global Neurokinin Receptor Antagonists API Market Research Report 2024
Global Fosaprepitant Dimeglumine API Market Research Report 2024
Global Aprepitant Injection Market Research Report 2025
Global Aprepitant Capsules Market Research Report 2025
Global Maropitant Citrate Market Research Report 2024
Global Maropitant Citrate Tablets Market Research Report 2024
Sumatriptan Succinate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroparesis Treatment Products Market Insights Forecast to 2030
Anti Emetic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aprepitant Preparations Market Research Report 2024
Global Maropitant Citrate API Market Research Report 2024
Global Quinidine Sulfate Market Insights Forecast to 2030
Global Triptan Market Insights Forecast to 2030
Global Domperidone API Market Research Report 2024
Global Prokinetic Drug Market Insights Forecast to 2030
Global Tirzepatide API Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions